Katie Coyle

Principal Scientist at Randox Health, USA

“The future of healthcare is not simply about treating disease earlier - it is about recognising biological change sooner, understanding patterns more intelligently and empowering more personalised intervention before illness develops.”

Katie Coyle, MChem, Principal Scientist at Randox Health USA, has spent more than 15 years helping translate advances in biomarker science, integrated diagnostics, and preventive healthcare into real-world clinical practice across Randox Health UK and the United States. Following master’s in chemistry studies and PhD research at ETH Zurich, Katie’s work has focused on bridging complex diagnostic science with meaningful clinical application. She specialises in translating health data into practical insights that support earlier intervention, personalised healthcare strategies for proactive patient management.